CCR9 and ovarian carcinoma: Johnson et al. demonstrated that ovarian cancer cells and tissue express CCR9, and the interaction between CCR9 and CCL25 increases anti-apoptotic signaling cascades in ovarian cells, which rescues cells from cisplatin-induced death [28].